Associated Papers
Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer.
Visser S et al.
Thorax, 2021
Pharmacogenetics of pemetrexed combination therapy in lung cancer: pathway analysis reveals novel toxicity associations.
Corrigan A et al.
The Pharmacogenomics Journal, 2014
Select a paper to view details